For example, we found the PAX5 gene to have a significantly higher rank in the IRENE list compared to the promoter-only list in the two CLL case studies, which implies that PAX5 is extensively regulated by enhancers. The gene discussed is PAX5; the disease is B-cell chronic lymphocytic leukemia.